AR014626A1 - Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento. - Google Patents
Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento.Info
- Publication number
- AR014626A1 AR014626A1 ARP990100675A ARP990100675A AR014626A1 AR 014626 A1 AR014626 A1 AR 014626A1 AR P990100675 A ARP990100675 A AR P990100675A AR P990100675 A ARP990100675 A AR P990100675A AR 014626 A1 AR014626 A1 AR 014626A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- independently selected
- phenyl
- substituents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Piridino arilpiperazinas sustituidas que comprende un compuesto de formula I, donde R1 es hidrogeno, halogeno, alcoxi C1-5, hidroxilo, o alquilo C1-5; R2es alquilo C1-6, alquilo C1-6 sustituido donde los sustituyentes de alquilo sonindependientemen te seleccionados entre uno o más halogenos, fenilo, fenilosustituido donde los sustituyentes de fenilo son independientemente seleccionados entre uno o más miembros del grupo que consiste de alquilo C1-5,alcoxi C1-5 ytrihaloalquilo C1-5, fenilalquilo C1-5, o fenilalquilo C1-5 sustituido donde los sustituyentes de fenilo se seleccionan independientementeentre uno o más miembros del grupo que consiste de alquilo C1-5, halogeno, alcoxi C1-5 ytrihaloalquilo C1-5; R3 es hidro geno, hidroxi, o alcoxi C1-5, sila línea punteada está ausente, o es oxígeno si la línea punteada está presente; R4 es hidrogeno, alquilo C1-5, fenilalquilo C1-5 o fenilalquilo C1-5sustituido, donde lossustituyentes de fenilo se seleccionan independientemente entre uno o más miembros del grupo que consiste de alquilo C1-5, alcoxi C1-5 ytrihaloalquilo C1-5; R5 es alquilo C1-6, alquilo C1-6 sustituido donde los sustituyentes de alquilo seseleccionan independientemente entre uno o m áshalogenos, fenilo, fenilo sustituido donde los sustituyentes de fenilo se seleccionan independientemente entre uno o más miembros del grupo que consistede alquilo C1-8, hidrogeno, hidroxi, alquiloC1-8, alquilo C1-8 sustituido donde los sustiyuyentes de alquilo se seleccionan independientemente entre unoo más halogenos, alcoxi C1-5, amino, alquil C1-5 amino, dialquil C1-5 amino, alquil C1-5 carbonilo, alcoxi C1-5 carbonilo,arilcarbonilo, nitrilo,aminosulfonilo, alquil C1-5 sulfo nilo, fenilsulfonilo y fenilsulfonilo sustituido donde los sustituyentes de fenilo se seleccionan independientemente
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7532198P | 1998-02-20 | 1998-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR014626A1 true AR014626A1 (es) | 2001-03-28 |
Family
ID=22124955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100675A AR014626A1 (es) | 1998-02-20 | 1999-02-23 | Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6218396B1 (es) |
| EP (1) | EP1054868B1 (es) |
| JP (1) | JP2002503724A (es) |
| KR (1) | KR100591028B1 (es) |
| CN (1) | CN1121390C (es) |
| AR (1) | AR014626A1 (es) |
| AT (1) | ATE250580T1 (es) |
| AU (1) | AU766398B2 (es) |
| BR (1) | BR9909647A (es) |
| CZ (1) | CZ294136B6 (es) |
| DE (1) | DE69911582T2 (es) |
| DK (1) | DK1054868T3 (es) |
| ES (1) | ES2209468T3 (es) |
| HK (1) | HK1030776A1 (es) |
| HU (1) | HUP0100781A3 (es) |
| IL (2) | IL137954A0 (es) |
| NO (1) | NO317103B1 (es) |
| NZ (1) | NZ506462A (es) |
| PL (1) | PL342339A1 (es) |
| PT (1) | PT1054868E (es) |
| TR (1) | TR200003220T2 (es) |
| TW (1) | TW565555B (es) |
| WO (1) | WO1999042448A1 (es) |
| ZA (1) | ZA991315B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1349A (en) * | 1997-05-12 | 2004-12-17 | Ortho Mcneil Pharm Inc | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia. |
| JP2004511438A (ja) | 2000-08-08 | 2004-04-15 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | イミダゾールを含有しないアリールオキシピペリジン |
| BR0215389A (pt) | 2001-12-28 | 2004-10-26 | Takeda Chemical Industries Ltd | Agente preventivo ou terapêutico para distúrbio urinário, método para prevenir ou tratar distúrbio urinário, uso de um composto, composto, pró-droga, processo para preparar o composto, medicamento, e, método para triar um composto |
| US8470859B2 (en) | 2006-10-23 | 2013-06-25 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
| MX2010011652A (es) * | 2008-04-23 | 2010-12-06 | Takeda Pharmaceutical | Derivados de iminopiridina y uso de los mismos. |
| US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
| US8481569B2 (en) | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
| CN103980195A (zh) * | 2014-04-28 | 2014-08-13 | 广州医科大学 | 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用 |
| CN108530391B (zh) * | 2018-05-17 | 2022-05-17 | 袁牧 | 一种酰胺类芳基哌嗪衍生物及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
| US5403847A (en) | 1992-11-13 | 1995-04-04 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperlasia |
| IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
| US5688795A (en) | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
| AU8130298A (en) * | 1997-07-15 | 1999-02-10 | Sankyo Company Limited | Piperazine derivatives |
-
1999
- 1999-02-18 ZA ZA9901315A patent/ZA991315B/xx unknown
- 1999-02-18 US US09/252,313 patent/US6218396B1/en not_active Expired - Lifetime
- 1999-02-19 BR BR9909647-1A patent/BR9909647A/pt not_active Application Discontinuation
- 1999-02-19 PT PT99934281T patent/PT1054868E/pt unknown
- 1999-02-19 DK DK99934281T patent/DK1054868T3/da active
- 1999-02-19 CZ CZ20003044A patent/CZ294136B6/cs not_active IP Right Cessation
- 1999-02-19 AT AT99934281T patent/ATE250580T1/de not_active IP Right Cessation
- 1999-02-19 IL IL13795499A patent/IL137954A0/xx active IP Right Grant
- 1999-02-19 TR TR2000/03220T patent/TR200003220T2/xx unknown
- 1999-02-19 HU HU0100781A patent/HUP0100781A3/hu unknown
- 1999-02-19 DE DE69911582T patent/DE69911582T2/de not_active Expired - Fee Related
- 1999-02-19 WO PCT/US1999/003608 patent/WO1999042448A1/en active IP Right Grant
- 1999-02-19 CN CN99803027A patent/CN1121390C/zh not_active Expired - Fee Related
- 1999-02-19 EP EP99934281A patent/EP1054868B1/en not_active Expired - Lifetime
- 1999-02-19 ES ES99934281T patent/ES2209468T3/es not_active Expired - Lifetime
- 1999-02-19 KR KR1020007009156A patent/KR100591028B1/ko not_active IP Right Cessation
- 1999-02-19 PL PL99342339A patent/PL342339A1/xx unknown
- 1999-02-19 NZ NZ506462A patent/NZ506462A/en unknown
- 1999-02-19 JP JP2000532400A patent/JP2002503724A/ja active Pending
- 1999-02-19 AU AU33025/99A patent/AU766398B2/en not_active Ceased
- 1999-02-23 AR ARP990100675A patent/AR014626A1/es active IP Right Grant
- 1999-04-02 TW TW088102511A patent/TW565555B/zh not_active IP Right Cessation
-
2000
- 2000-08-18 IL IL137954A patent/IL137954A/en not_active IP Right Cessation
- 2000-08-18 NO NO20004141A patent/NO317103B1/no not_active IP Right Cessation
-
2001
- 2001-03-08 HK HK01101679A patent/HK1030776A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0100781A3 (en) | 2002-12-28 |
| CZ294136B6 (cs) | 2004-10-13 |
| CZ20003044A3 (cs) | 2001-04-11 |
| HUP0100781A2 (hu) | 2001-08-28 |
| EP1054868B1 (en) | 2003-09-24 |
| CN1291188A (zh) | 2001-04-11 |
| US6218396B1 (en) | 2001-04-17 |
| KR100591028B1 (ko) | 2006-06-22 |
| PT1054868E (pt) | 2004-01-30 |
| BR9909647A (pt) | 2000-11-21 |
| IL137954A0 (en) | 2001-10-31 |
| NO20004141D0 (no) | 2000-08-18 |
| WO1999042448A1 (en) | 1999-08-26 |
| ATE250580T1 (de) | 2003-10-15 |
| EP1054868A1 (en) | 2000-11-29 |
| JP2002503724A (ja) | 2002-02-05 |
| KR20010041115A (ko) | 2001-05-15 |
| ZA991315B (en) | 2000-11-20 |
| NO317103B1 (no) | 2004-08-09 |
| AU3302599A (en) | 1999-09-06 |
| TR200003220T2 (tr) | 2001-04-20 |
| DE69911582D1 (de) | 2003-10-30 |
| DE69911582T2 (de) | 2005-09-15 |
| PL342339A1 (en) | 2001-06-04 |
| HK1030776A1 (en) | 2001-05-18 |
| IL137954A (en) | 2007-06-03 |
| ES2209468T3 (es) | 2004-06-16 |
| TW565555B (en) | 2003-12-11 |
| NO20004141L (no) | 2000-10-19 |
| NZ506462A (en) | 2003-07-25 |
| CN1121390C (zh) | 2003-09-17 |
| DK1054868T3 (da) | 2003-12-22 |
| AU766398B2 (en) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20000380B1 (en) | Oral pharmaceutical extended release dosage form | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| AR032781A1 (es) | Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| NL300338I2 (nl) | Triazolytropaanderivaten als ccr5-modulatoren | |
| PE20021088A1 (es) | Amidas de acidos antranilicos, procedimiento para su preparacion asi como preparados farmaceuticos que las contienen | |
| AR014626A1 (es) | Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento. | |
| AR054688A1 (es) | Alquil-piridinas como inhibidores 11-beta de la diabetes | |
| CO5640136A2 (es) | Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen | |
| AR038818A1 (es) | Compuesto de piperidina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
| NO20044767L (no) | Farmasoytisk formulering med modifisert frigjoring | |
| GEP20094638B (en) | Benzimidazolone carboxylic acid derivatives | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| NO20054787L (no) | Indenderivater som farmasotiske midler | |
| RS53180B (en) | NEW SEH INHIBITORS AND THEIR USE | |
| AR032466A1 (es) | Ciclilamina sulfonamidas, utilizacion de las mismas para la manufactura de un medicamento y composiciones farmaceuticas utiles como agonistas de los receptores beta-3 adrenergicos | |
| CA2655527C (en) | Cinnamoyl-piperazine derivatives and their use as par-1 antagonists | |
| GEP20053505B (en) | Diphenyl Ether Compounds Useful in Therapy | |
| AR057464A1 (es) | Procedimiento para la preparacion de derivados de sulfonamida | |
| AR022824A1 (es) | Inhibidores de metaloproteasa dihetero-sustituida | |
| HUP0303737A2 (hu) | 6-helyzetben szubsztituált indolinonok és alkalmazásuk kináz inhibitorokként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata | |
| DK1202954T3 (da) | Nye aminobenzophenoner | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| AR035110A1 (es) | Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |